↓ Skip to main content

Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma

Overview of attention for article published in Cochrane database of systematic reviews, April 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

policy
1 policy source
twitter
1 tweeter
wikipedia
1 Wikipedia page

Citations

dimensions_citation
111 Dimensions

Readers on

mendeley
147 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma
Published in
Cochrane database of systematic reviews, April 2010
DOI 10.1002/14651858.cd005533.pub2
Pubmed ID
Authors

Francine M Ducharme, Muireann Ni Chroinin, Ilana Greenstone, Toby J Lasserson

Abstract

In asthmatic patients inadequately controlled on inhaled corticosteroids and/or those with moderate persistent asthma, two main options are recommended: the combination of a long-acting inhaled ss2 agonist (LABA) with inhaled corticosteroids (ICS) or use of a higher dose of inhaled corticosteroids.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 147 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 1%
United Kingdom 1 <1%
Ireland 1 <1%
Korea, Republic of 1 <1%
Colombia 1 <1%
Unknown 141 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 27 18%
Student > Master 22 15%
Student > Bachelor 20 14%
Other 19 13%
Student > Ph. D. Student 16 11%
Other 43 29%
Readers by discipline Count As %
Medicine and Dentistry 86 59%
Unspecified 17 12%
Nursing and Health Professions 12 8%
Pharmacology, Toxicology and Pharmaceutical Science 9 6%
Psychology 5 3%
Other 18 12%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 December 2017.
All research outputs
#2,110,798
of 12,527,093 outputs
Outputs from Cochrane database of systematic reviews
#4,365
of 8,923 outputs
Outputs of similar age
#26,054
of 146,345 outputs
Outputs of similar age from Cochrane database of systematic reviews
#48
of 116 outputs
Altmetric has tracked 12,527,093 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one has gotten more attention than average, scoring higher than 53% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 146,345 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 116 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.